Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × ravulizumab × 90 days × Clear all

Phase

Status

Recruiting 2 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1 Adrenal Insufficiency 1

Interventions

Specimen Handling 46 Carboplatin 34 Magnetic Resonance Spectroscopy 33 Cyclophosphamide 30 Paclitaxel 29 Oxaliplatin 29 pembrolizumab 28 Cisplatin 28 Gemcitabine 27 Drug Therapy 25 Biopsy 25 Capecitabine 24 Bevacizumab 22 Radiotherapy 20 Docetaxel 20 Fluorouracil 19 venetoclax 18 Standard of Care 18 tislelizumab 17 Nivolumab 17 Injections 17 toripalimab 16 Azacitidine 16 fludarabine 15 Leucovorin 14 Irinotecan 13 Dexamethasone 13 cemiplimab 12 Radiosurgery 12 Pemetrexed 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-03-03

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Not yet recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡